In order to fully mature and participate in the humoral immune response, immature B cells must first migrate into specific areas in the spleen where they differentiate into mature cells. However, before their maturation in the spleen, immature B cells must be excluded from non-splenic secondary lymphoid organs where any antigen encounter would lead to the death of the cells because of the negative selection process. We have recently shown that immature B cells can actively exclude themselves from antigen-enriched sites by down-regulating their integrin-mediated adhesion in a process mediated by interferon-␥ (IFN-␥). In this study, we followed the pathway by which IFN-␥ regulates the homing of B cells. We show here that the inhibitory signal of IFN-␥ is transmitted through the IFN-␥ receptor whose engagement leads to the activation of PI3K. This PI3K activation subsequently leads to the inhibition of PKC␣ phosphorylation and cytoskeleton rearrangement required for promoting integrin-mediated adhesion and migration of B cells.
Immune cells are characterized by cellular movement between compartments that enables their mobilization and deployment to the sites of pathogen challenge. One of the most important facilitators of leukocyte migration is chemokines, which bind a large subfamily of G protein-coupled receptors. The targeted transmigration of leukocytes from peripheral blood into extravascular tissues is an important component of both immune surveillance and the inflammatory response. The adhesion of peripheral blood leukocytes to the endothelium in secondary lymphoid tissues or at peripheral sites of inflammation and their migration through the endothelium is a multiplestep process. Transient interactions with the vessel walls that enable rolling are followed by chemoattractant-mediated activation signals, which promote firm adhesion among integrin molecules on leukocytes and immunoglobulin superfamily ligands on the endothelium. In the next step lymphocytes are spread on the apical endothelial surface. Finally, cells migrate through intercellular borders and transmigrate beneath the monolayers (1) (2) (3) (4) (5) (6) (7) (8) .
Immature B cells emerge from the bone marrow to the periphery and migrate into the spleen for their final maturation step. This migration proceeds through the terminal branches of central arterioles to blood sinusoids of the marginal zone (9, 10). Newly created B cells then penetrate the marginal zone sinus ending up in the outer zone of the periarteriolar lymphocytic sheath (11) . Before arriving to the spleen, immature B cells must be excluded from non-splenic secondary lymphoid organs, which are specialized tissues for collecting antigens (12) , and from sites of infection and inflammation. In these secondary lymphoid organs in which differentiation to a mature phenotype does not occur, any antigen encounter would lead to the death of the immature B cells and thus the elimination of effective clones because of the negative selection process.
Recently, we have demonstrated that immature B cells can down-regulate their own integrin-mediated adhesion to the extracellular matrix and consequently suppress their migration, as well as that of mature B cells, into non-splenic sites of antigen presentation. In this way, immature B cells prevent premature encounter with antigen by autocrine down-regulation of their own migration. This inhibition is mediated by IFN-␥, 1 which is transcribed and secreted by immature B cells but is dramatically down-regulated in mature B cells. Thus, IFN-␥ has an inhibitory effect on the adhesion and migration of B cells (13) .
Here, we analyzed the signaling pathway controlled by IFN-␥ that is responsible for regulating the B cell homing. Interestingly, our studies revealed that low levels of IFN-␥ initiate a cascade through the IFN-␥ receptor involving PI3K, which interferes with the chemokine receptor-signaling pathway that involves PKC␣. The down-regulation of PKC␣ phosphorylation results in the inhibition of adhesion and migration of B cells.
MATERIALS AND METHODS

Cells-
The murine pre-B cell-like lymphoma line 70Z/3 (14) was grown in suspension culture at 37°C in RPMI 1640 medium containing 10% (v/v) fetal calf serum and 200 M ␤-mercaptoethanol. Primary B cells were obtained from control C57BL/6 and were purified by treating the splenocyte suspension with anti-Thy 1.2, CD4, and CD8 (Southern Biotechnology Associates, Inc.) followed by low Tox-M complement (Cederlane). Immature B Cell-conditioned Medium-Conditioned medium was collected from immature B cells from invariant chain-deficient mice (15) as described previously (13) .
Adhesion Assays-Adhesion assays were performed as described previously (13) .
Transwell Migration-Chemotaxis was assayed by using transwell chambers (diameter ϭ 6.5 mm, pore ϭ 5 m) (Corning Inc., Corning, NY). Approximately 5 ϫ 10 6 70Z/3 cells were suspended in 1 ml of RPMI 1640 medium with 0.25% fetal calf serum. Next, 100 l was placed in the upper compartment of the transwell apparatus and 600 l of medium with or without 1 g/ml SDF-1 (PeproTech, Inc., Rocky Hill, NJ) was placed in the bottom chamber. The migration toward the chemokine SDF-1, residing in the lower part of the apparatus, was analyzed after 3 h by FACS in the presence or absence of IFN-␥ or conditioned medium collected from invariant chain-deficient cells. In some experiments, cells were pre-incubated with anti-INF-␥ receptor or anti-CD8 antibodies (PharMingen) for 2.5 h before the transwell assay.
Lysis of Cells-70Z/3 cells were pre-incubated with or without conditioned medium collected from immature B cells or IFN-␥ in the presence or absence of inhibitors for 30 min. The cells were then stimulated for 5 min with 0.2 g/ml PMA and immediately frozen. Then the cells were lysed in lysis buffer containing 25 mM Tris, pH 7.4, 2 mM Vanadate, 75 mM ␤-glycophosphate, pH 7.2, 2 mM EDTA, 2 mM EGTA, 10 mM NaPPi, 0.5% Nonidet P-40 in the presence of the following protease inhibitors: 10 g/ml leupeptin, 10 g/ml aprotinin, 10 g/ml pepstatin, 10 g/ml chymostatin (Roche Molecular Biochemicals), 1 mM phenylmethylsulfonyl fluoride (Sigma), and 20 mM N-ethylmaleimide (Sigma).
Western Blot Analysis-Lysates or immunoprecipitates of p-tyr proteins were separated by 10% (w/v) SDS-polyacrylamide gel electrophoresis. The proteins were transferred onto nitrocellulose and probed with anti p-AKT (Cell Signaling Technology), anti p-tyr (pTyr99), or PKC␣ (C-20) (Santa Cruz Biotechnology) followed by horseradish peroxidase-conjugated anti-mouse or rabbit IgG (Jackson Laboratories).
Cytoskeleton Rearrangement-70Z/3 or primary B cells were preincubated in the presence or absence of immature B cell-conditioned medium or 0.1 unit/ml IFN-␥ with or without the PI3K inhibitors wortmannin or LY29004 for 30 min. The cells were then washed and stimulated for 20 s with 500 ng/ml SDF-1 and immediately fixed by adding a 3-fold volume of 3.7% paraformaldehyde for 10 min at room temperature. Next, the cells were washed, and the membranes were permeabilized for 2 min on ice in a solution containing HEPES (20 mM), sucrose (300 mM), NaCl (50 mM), MgCl 2 (3 mM), and Triton X-100 (0.1%). Finally, the cells were stained with fluorescein isothiocyanatephalloidin (2 g/ml), washed with phosphate-buffered saline, and analyzed by flow cytometry. The percentage increase of polymerized actin was calculated by subtracting the mean value of polymerized actin of non-activated cells from the mean value of activated cells and dividing it to the mean value of the non-activated cells multiplied by 100%.
Inhibitors-The PI3K inhibitors used were wortmannin (100 nM, Calbiochem) or LY29004 (200 mM, Calbiochem). The PKC inhibitors used were PKC␣/␤ pseudosubstrate (10 M, BioMol Research Laboratories), myristoylated-autocamtide-2-related inhibitory peptide, CaM kinase II inhibitor (10 g/ml, BioMol Research Laboratories), the PKC␦ inhibitor, rottlerin (5 M, Calbiochem), and the PKC inhibitor, GF-109203X (bisindaylmaleimide I) (0.5 M, Calbiochem). We wanted to identify a cell line that could increase its adhesion and migration as a consequence of chemokine stimulation, whereas low levels of IFN-␥ inhibit the ability of the cells to respond. The 70Z/3 cell line is a murine pre-B lymphoma that meets these requirements. After PMA (Fig. 1A) or SDF-1 (Fig.  1B ) stimulation, these cells increased their adhesion response, whereas conditioned medium derived from immature B cells (sup) and low levels of IFN-␥ down-regulated this adhesion process. High levels of IFN-␥ had no effect on the adhesion response.
RESULTS
A Cell Line Model for the Regulation of B Cell Migration by IFN-␥-Low
We further studied the effect of the inhibitory treatment of immature B cell-conditioned medium and IFN-␥ on the transwell migration of 70Z/3 cells toward the chemokine SDF-1. As shown in Fig. 1C , cells pre-incubated with these inhibitors markedly down-regulated their migration toward SDF-1. Thus, 70Z/3 cells respond to various stimuli and are sensitive to the inhibitory treatments, similarly to primary B cells. Therefore, they serve as an appropriate system to monitor the signaling pathway induced by IFN-␥.
The Role of the IFN-␥ Receptor-To determine whether the IFN-␥-induced inhibition of cell adhesion and migration is initiated by the IFN-␥ receptor (IFNR) (16, 17) or by a novel receptor not previously described, we analyzed the involvement of this receptor in the inhibitory pathway. 70Z/3 cells were pre-treated for 3 h with anti-IFN-␥ receptor or anti-CD8 antibodies. Cells were then washed and stimulated with PMA in the presence or absence of IFN-␥ or immature B cell-conditioned medium. As shown in Fig. 2A , whereas control antibodies (anti-CD8) did not influence the inhibitory effect of the conditioned medium and IFN-␥, the antibodies against the 51 Cr, washed, and resuspended in adhesion medium or immature B cell-conditioned medium (sup) in the presence or absence of PMA (0.2 g/ml) (A) or SDF-1 (50 g/ml) stimulation with or without IFN-␥ (B). The adherent cells were lysed, and radioactivity was determined. One experiment representative of five is depicted. C, cells were placed in the presence or absence of sup or IFN-␥ (0.1 or 10 units/ml) on 24-well transwell plates in the presence or absence of SDF-1 (1 g/ml). Migration was measured after 3 h of incubation and was analyzed by FACS. The data depict one experiment representative of three.
interferon-␥ receptor dramatically abrogated the inhibitory effect of the cell supernatant or IFN-␥.
To further demonstrate that IFNR binds IFN-␥ and regulates migration, we monitored the transwell migration of 70Z/3. Whereas the migration of cells pre-treated with antibodies against the IFN-␥ receptor in the presence of IFN-␥ was similar to the migration of wild-type cells, control anti-CD8 antibodies could not reverse the inhibited migration of the cells (Fig. 2B) . Thus, blocking the binding of IFN-␥ reversed the inhibition induced by this cytokine. Therefore, low levels of IFN-␥ that are sufficient to inhibit the adhesion and migration of cells are recognized by the IFN-␥ receptor, which transmits a signal that perturbs the cell adhesion response.
The Downstream Target of IFN-␥ Receptor Signaling-To monitor downstream molecules involved in IFN-␥-induced adhesion regulation, we studied the effect of various signal transduction inhibitors in reversing the inhibitory effect of IFN-␥. Although SB-202190 (data not shown) and PD-98059 (Fig. 3A) did not affect the inhibition of this cytokine in the presence of the PI3K inhibitor wortmannin, adhesion was dramatically increased (Fig. 3A) . We further studied the role of the PI3K inhibitors, wortmannin or Ly-294002, in the IFN-␥-induced inhibition. PI3K inhibitors, as previously described, slightly suppressed SDF-1-stimulated 70Z/3 cell adhesion on their own (18) . However, these inhibitors also reversed the immature B cell-conditioned medium and IFN-␥ inhibition of the adhesion response. Cells treated with either immature B cell-conditioned medium or IFN-␥ in the presence of PI3K inhibitors adhered to fibronectin similarly to cells incubated in the presence of PMA and wortmannin or Ly-294002 (Fig. 3B ). This demonstrates a potential role for PI3K in the adhesion of cells. To determine the involvement of PI3K in IFN-␥-induced inhibition, we sought to determine whether the Akt kinase, a known downstream element of the phosphatidylinositol 3Ј-kinase pathway (19) , is activated by this cytokine. As shown in Fig. 3C , in the presence of IFN-␥ there was an increased Akt phosphorylation demonstrating that Akt kinase is a downstream effector of the phosphatidylinositol 3Ј-kinase in IFN-␥ signaling. In the presence of higher levels of IFN-␥, a reduced phosphorylation of Akt was observed (Fig. 3D) showing a dose dependence of the effect of this cytokine on Akt phosphorylation.
To follow downstream molecules involved in IFN-␥-induced adhesion regulation, we analyzed the effect of IFN-␥ on tyrosine phosphorylation of proteins following PMA stimulation of 70Z/3 cells. Cells were treated with PMA in the presence or absence of IFN-␥ or immature B cell-conditioned medium. Our targets were proteins, which could respond to PMA by changing their tyrosine phosphorylation levels and whose PMA re and their proteins were analyzed for tyrosine phosphorylation by Western blot analysis. An 85-kDa protein was significantly phosphorylated following PMA induction. Stimulated cells, which were incubated with IFN-␥ (Fig. 4A) , or immature B cell-conditioned medium (Fig. 4B ) exhibited reduced phosphorylation, suggesting the negative regulation of the tyrosinephosphorylation signaling pathway via a specific protein in this cascade.
The 85-kDa protein appeared to be a key element in the IFN-␥-controlled adhesion pathway. To identify this protein, we followed the phosphorylation of various known proteins with a molecular weight of approximately 85. Proteins from PMA-induced or non-induced cells, which were incubated in the presence or absence of IFN-␥, were immunoprecipitated with anti-phosphotyrosine antibodies and analyzed by Western blot with antibodies against various known proteins. As shown in Fig. 4C , the appearance of PKC␣ matched the pattern observed in the phosphotyrosine blot showing an elevation in phosphorylation after PMA stimulation and down-regulation of this process by IFN-␥. In addition, the treatment of the cells with wortmannin restored the phosphorylation of PKC␣, suggesting the involvement of PI3K in the IFN-␥-induced inhibition of adhesion (Fig. 4D) . This sensitivity to IFN-␥ was specific to PKC␣, because the phosphorylation of PKC␦ was not af- fected by this cytokine (data not shown). Consistent with this notion, the PKC␣/␤ pseudosubstrate inhibitor dramatically down-regulated the adhesion of PMA or SDF-1-stimulated cells to fibronectin (Fig. 4E) .
Among the requirements for inducible integrin-mediated adhesion are an increased rate of actin polymerization and the extensive reorganization of the actin-based cytoskeleton. Chemokines promote a rapid burst of actin polymerization, which peaks at 30 s to 1 min and subsides to base-line levels within 5-10 min post-stimulation. To determine whether the adhesion inhibition induced by IFN-␥ involves the inhibition of cytoskeletal rearrangement, we monitored actin polymerization in 70Z/3 cells that were pre-incubated in the presence or absence of IFN-␥ and stimulated by SDF-1. The cells were immediately fixed with paraformaldehyde and then permeabilized and stained with fluorescein isothiocyanate-phalloidin and analyzed by flow cytometry for their cytoskeleton rearrangement. As shown in Fig. 5A , SDF-1 stimulation induced actin polymerization, which was dramatically down-regulated by immature B cell-conditioned medium or IFN␥. Thus, low levels of IFN-␥ inhibit adhesion by decreasing cytoskeleton rearrangement. In the presence of IFN-␥ and the PI3K inhibitors, wortmannin or LY-294002, actin polymerization was restored (Figs. 5, C and D) allowing the adhesion of the cells, which indicates that PI3K is involved in IFN-␥ down-regulation of actin polymerization. Both the PKC inhibitor GF 109203X and a PKC␣/␤ pseudosubstrate inhibitor blocked the actin polymerization induced by SDF-1, whereas the PKC␦ inhibitor did not have any effect (Fig. 5B) , demonstrating that PKC␣ is indeed a crucial downstream component of the SDF-1-induced adhesion and migration pathway.
Finally, to show that IFN-␥ inhibits primary B cell adhesion using the pathway described earlier, we analyzed the role of PI3K and PKC␣ in the polymerization of actin in these cells. Similar to 70Z/3 cells, low levels of IFN-␥ strikingly downregulated the actin polymerization of the B splenocytes (Fig.  6A) , showing that the lack of adhesion induced by IFN-␥ is because of its effect on the organization of the cytoskeleton. The PI3K inhibitor LY-294002, although its own partial inhibitory effect on actin polymerization, increased the IFN-␥-inhibited cytoskeleton rearrangement (Fig. 6A) . In addition, the PKC␣/␤ pseudosubstrate down-regulated the SDF-1-induced actin polymerization while a control peptide, an inhibitor of CaM kinase II, had no effect on this response (Fig. 6B) . Thus, the IFN-␥ inhibitory pathway in B splenocytes uses the same key molecules as determined for 70Z/3 cells.
Therefore, IFN-␥ down-regulates the adhesion of B cells by a pathway initiated by the IFN-␥ receptor. The activation of this receptor consequently induces a PI3K-signaling cascade, which inhibits PKC␣ phosphorlyation. This process results in the down-regulation of actin polymerization and cell adhesion and migration.
DISCUSSION
Cell migration is controlled by multi-step processes that include chemoattraction, cell-cell adhesion, and transmigration through cell layers (20, 21) . Chemotactic signals play important roles in leukocyte navigation by regulating the migration from the blood into tissues, as well as subsequent localization within the microenvironment of these tissues. Chemokines transmit directional signals to leukocytes by binding to seven-transmembrane receptors that are coupled to pertussis toxin-inhibitable heterotrimers (22) . Several chemokines attract primary B cells and play a role in the homing and microenvironmental localization of B cell subsets at different stages of antigen-dependent and antigen-independent B cell differentiation (23) . We have previously shown that immature B cells are able to auto-inhibit their homing to antigen-enriched compartments. This regulation is mediated by autocrine secretion of low levels of interferon-␥, which inhibits the response of cells to chemokine stimulation and their ability to adhere to the extracellular matrix component, fibronectin (13) .
In this study, we analyzed the mechanism by which IFN-␥ regulates the homing of B cells. We have demonstrated that the IFN-␥ receptor is responsible for the inhibitory effect induced by IFN-␥. This receptor transmits a signal through PI3K that results in the inhibition of actin polymerization and the extensive reorganization of the actin-based cytoskeleton, which is required for inducible integrin-mediated adhesion. The involvement of IFNR in IFN-␥-induced homing inhibition suggests that this receptor binds both low and high levels of IFN-␥, however, the outcome response is different. Whereas high levels of IFN-␥ augment the inflammatory response, binding low levels of this cytokine induces a down-regulation of adhesion and migration of cells and consequently the inhibition of the immune response.
We have shown that the inhibitory signal transmitted by this receptor involves the PI3K. The IFN-␥ receptor consists of two distinct subunits, IFNR1 and IFNR2. The major ligand-binding subunit is IFNR1, which also plays an important role in IFN-␥ signaling (16, 17) . IFNR2 plays a minimal role in ligand binding, but its signaling function is critical in the generation of IFN-␥ signals (16, 24, 25) . The signaling cascades activated by the IFN-␥ receptor involve the two tyrosine kinases associated with the IFNR1 and IFNR2 receptor subunits, Jak-1 and Jak-2 (26 -28). Upon ligand binding, these subunits phosphorylate IFNR1, providing docking sites for the Stat-1 transcriptional activator. Several other components are activated during the engagement of this receptor including the SHP-1 and SHP-2 phosphatases, CrkL and CrkII, respectively, and the Vav protooncogene (29) . In addition, IFN-␥ was shown to stimulate the tyrosyl phosphorylation of the insulin receptor substrate 1. Insulin receptor substrate 1 may interact with JAK2 or an auxiliary molecule that binds to JAK2 (30) . It has been demonstrated that the Src homology 2 domains from the 85-kDa regulatory subunit of PI3K bind to unique residues within insulin receptor substrate 1 (31) . Therefore, the IFN-␥ receptor might activate a cascade through insulin receptor substrate 1, which binds to PI3K.
The involvement of PI3K in chemotaxis has been investigated with contradictory results from various studies. For example, treatment with PI3K inhibitors, including Wortmannin and LY-294002, inhibited chemotaxis in some studies (32) (33) (34) but not in others (35) . Studies of mice lacking PI3K␥ showed that PI3K␥ appears to play an important role necessary for neutrophil chemotaxis (36 -38) . The importance of PI3K␥ in chemotaxis appears to be restricted to the myeloid lineage, because PI3K␥ deficiency does not alter the chemotactic activities of spleen B cells in response to SDF-1, MIP3␤, or fractalkine (39) . In our studies, we showed that PI3K has a role in the adhesion of B cells, its inhibition slightly down-regulates their cytoskeleton rearrangement and adhesion. However, PI3K plays a crucial role in the negative regulation of the adhesion and migration of cells induced by IFN-␥. In the presence of IFN-␥, there is increased Akt phosphorylation, demonstrating that Akt kinase is a downstream effector of the phosphatidylinositol 3Ј-kinase in IFN-␥ signaling. Furthermore, the adhesion and cytoskeleton rearrangement of cells treated with IFN-␥ in the presence of the PI3K inhibitor were dramatically up-regulated and retrieved adhesion, showing that despite its inhibitory effect on adhesion it inhibits the IFN-␥ effect.
Our studies show that SDF-1 and PMA induce adhesion and migration of cells by activating PKC␣. Following PMA activation, PKC␣ is phosphorylated and translocates to the membranes (data not shown). In addition, SDF-1 activation leads to augmented cytoskeletal rearrangement, a process that is downregulated by a specific PKC␣/␤ inhibitor. Thus, stimulation of B cells leads to actin polymerization and adhesion by a PKC␣-mediated pathway. It was previously shown that the unphosphorylated primary translation product of PKC␣ has little or no activity. Upon ligand binding at the membrane, PKC becomes a substrate for kinases acting on the activation loop and hydrophobic C-terminal sites on the PKC molecule. Following subsequent autophosphorylation, the kinase domain acquires a closed conformation that confers stability and phosphatase resistance (40) . We show here that low levels of IFN-␥ are sufficient to inhibit B cell adhesion and migration by down-regulating the PKC␣ phosphorylation, resulting in reduced actin polymerization and consequently reduced cell adhesion. Blocking the IFNR signal by the PI3K inhibitor, wortmannin restored PKC␣ phosphorylation, a process that results in the up-regulation of adhesion.
The results presented here demonstrate that the secretion of low levels of IFN-␥ by immature B cells inhibit the adhesion and migration of B cells by interfering with the chemokine receptor-signaling pathway, which results in the inhibition of cytoskeleton rearrangement and adhesion.
